| 08:00-08:30 | 专题报告 |
气道基底干细胞治疗慢性肺病研究进展 |
|
||||
| 08:30-09:00 | 专题报告 |
变应原特异性免疫治疗临床进展 |
|
||||
| 09:00-09:05 | 讨论 |
集体答疑、讨论 |
|||||
| 09:05-09:13 | 大会发言 |
Population Pharmacokinetic-Pharmacodynamic Analysis and Dose Optimization of Ciprofol in Paediatric Anaesthesia |
|
||||
| 09:13-09:21 | 大会发言 |
Pediatric Safety Evaluation of Baloxavir Marboxil in FAERS: A Multidisciplinary Expert Panel Case-by-Case Review |
|
||||
| 09:21-09:29 | 大会发言 |
Comparison of Anesthetic Effects and Post-procedure Recovery Between Oliceridine and Sufentanil for Fiberoptic Bronchoscopy in Children: A Prospective Randomized Controlled Study |
|
||||
| 09:29-09:37 | 大会发言 |
Influence of Physiological and Pathological Factors on Tocilizumab Pharmacokinetics: A Population Analysis in Pediatric Patients Using Real-World Data |
|
||||
| 09:37-09:45 | 大会发言 |
自乳化给药系统降低儿童与成人间药动学变异的肠屏障调控机制研究 |
|
||||
| 09:45-09:53 | 大会发言 |
小胶质细胞及IL-2/MCP-1在可乐定对TD鼠 抽动行为影响中的作用 |
|
||||
| 09:53-10:01 | 大会发言 |
基于粪菌移植模型探究芍药苷治疗儿童功能性消化不良的作用机制 |
|
||||
| 10:01-10:09 | 大会发言 |
纳米砷剂激活肿瘤细胞焦亡的机制研究 |
|
||||
| 10:09-10:17 | 大会发言 |
Timing Matters: Tacrolimus Intra-patient Variability Within the Initial Seven Months Forecasts De Novo DSA and Subsequent Rejection in a Chinese Kidney Transplant Cohort |
|
||||
| 10:17-10:25 | 大会发言 |
Anti-seizure Medications and DRESS in Pediatric Patients: A FAERS Disproportionality and Time-to-Onset Analysis |
|
||||
| 10:25-10:33 | 大会发言 |
A Rapid Isocratic LC-MS/MS Method for the Quantification of Busulfan in Human Plasma and Its Clinical Application in Pediatric Bone Marrow Transplantation |
|
||||
| 10:33-10:41 | 大会发言 |
Longitudinal Monitoring of Treatment-Associated Gonadal Impairment in Pediatric Lymphoma |
|
||||
| 10:41-10:49 | 大会发言 |
基于SPE-微孔分光光度法的甲氨蝶呤血药浓度快速检测试剂盒的研发及临床应用研究 |
|
||||
| 10:49-10:57 | 大会发言 |
儿童急性淋巴细胞白血病患者甲氨蝶呤群体药动学特征及影响因素研究 |
|
||||
| 10:57-11:05 | 大会发言 |
Population Pharmacokinetics and Probability of Target Attainment of Tigecycline in Critically Ill Children |
|
||||
| 11:05-11:13 | 大会发言 |
CTSZ介导IARS1相关肺泡蛋白沉积症的发生机制及潜在干预策略 |
|
||||||||||||||
| 11:13-11:28 | 大会发言 |
病例报告:一例儿童使用吗替麦考酚酯致肌无力样不良反应的药学监护 |
|
||||||||||||||
| 11:28-11:58 | 讨论 |
集体答疑、讨论 |
|
||||||||||||||
| 11:58-12:10 | 总结 |
临床药理分会场闭幕式 |
|
||||||||||||||